Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19988
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCarvill, Gemma L-
dc.contributor.authorEngel, Krysta L-
dc.contributor.authorRamamurthy, Aishwarya-
dc.contributor.authorCochran, J Nicholas-
dc.contributor.authorRoovers, Jolien-
dc.contributor.authorStamberger, Hannah-
dc.contributor.authorLim, Nicholas-
dc.contributor.authorSchneider, Amy L-
dc.contributor.authorHollingsworth, Georgie-
dc.contributor.authorHolder, Dylan H-
dc.contributor.authorRegan, Brigid M-
dc.contributor.authorLawlor, James-
dc.contributor.authorLagae, Lieven-
dc.contributor.authorCeulemans, Berten-
dc.contributor.authorBebin, E Martina-
dc.contributor.authorNguyen, John-
dc.contributor.authorBarsh, Gregory S-
dc.contributor.authorWeckhuysen, Sarah-
dc.contributor.authorMeisler, Miriam-
dc.contributor.authorBerkovic, Samuel F-
dc.contributor.authorDe Jonghe, Peter-
dc.contributor.authorScheffer, Ingrid E-
dc.contributor.authorMyers, Richard M-
dc.contributor.authorCooper, Gregory M-
dc.contributor.authorMefford, Heather C-
dc.date.accessioned2019-01-02T01:14:03Z-
dc.date.available2019-01-02T01:14:03Z-
dc.date.issued2018-12-06-
dc.identifier.citationAmerican journal of human genetics 2018; 103(6): 1022-1029-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/19988-
dc.description.abstractDevelopmental and epileptic encephalopathies (DEEs) are a group of severe epilepsies characterized by refractory seizures and developmental impairment. Sequencing approaches have identified causal genetic variants in only about 50% of individuals with DEEs.1-3 This suggests that unknown genetic etiologies exist, potentially in the ∼98% of human genomes not covered by exome sequencing (ES). Here we describe seven likely pathogenic variants in regions outside of the annotated coding exons of the most frequently implicated epilepsy gene, SCN1A, encoding the alpha-1 sodium channel subunit. We provide evidence that five of these variants promote inclusion of a "poison" exon that leads to reduced amounts of full-length SCN1A protein. This mechanism is likely to be broadly relevant to human disease; transcriptome studies have revealed hundreds of poison exons,4,5 including some present within genes encoding other sodium channels and in genes involved in neurodevelopment more broadly.6 Future research on the mechanisms that govern neuronal-specific splicing behavior might allow researchers to co-opt this system for RNA therapeutics.-
dc.language.isoeng-
dc.subjectDravet syndrome-
dc.subjectSCN1A-
dc.subjectalternative splicing-
dc.subjectepilepsy-
dc.subjectgenome sequencing-
dc.subjectnoncoding-
dc.subjectpoison exon-
dc.subjectvariant interpretation-
dc.titleAberrant Inclusion of a Poison Exon Causes Dravet Syndrome and Related SCN1A-Associated Genetic Epilepsies.-
dc.typeJournal Article-
dc.identifier.journaltitleAmerican journal of human genetics-
dc.identifier.affiliationDepartment of Human Genetics, University of Michigan, Ann Arbor, MI 48109, USAen
dc.identifier.affiliationNeurogenetics Group, Center for Molecular Neurology, VIB, Antwerp 2610, Belgium; Department of Neurology, University Hospital Antwerp, Antwerp 2610, Belgiumen
dc.identifier.affiliationHudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, USAen
dc.identifier.affiliationDepartment of Biochemistry and Molecular Genetics, Anschutz School of Medicine, University of Colorado Denver, Denver, CO 80204, USAen
dc.identifier.affiliationDepartment of Neurology, University Hospital Antwerp, Antwerp 2610, Belgiumen
dc.identifier.affiliationUniversity of Melbourne, Royal Children's Hospital, Murdoch Children's Research Institute, Florey Institute, Melbourne, VIC 3084, Australiaen
dc.identifier.affiliationLaboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp 2610, Belgiumen
dc.identifier.affiliationDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60610, USAen
dc.identifier.affiliationUniversity of Alabama at Birmingham, Birmingham, AL 35294, USAen
dc.identifier.affiliationEpilepsy Research Centre, Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationHudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, USAen
dc.identifier.affiliationDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA 98195, USAen
dc.identifier.affiliationDepartment of Development and Regeneration - Section Pediatric Neurology, University Hospitals KU Leuven, Leuven 3000, Belgium-
dc.identifier.affiliationDepartment of Pediatric Neurology, University and University Hospital Antwerp, Antwerp 2610, Belgium-
dc.identifier.affiliationHudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, USA-
dc.identifier.affiliationDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA 98195, USA-
dc.identifier.doi10.1016/j.ajhg.2018.10.023-
dc.identifier.orcid0000-0002-2311-2174-
dc.identifier.orcid0000-0003-4580-841X-
dc.identifier.pubmedid30526861-
dc.type.austinJournal Article-
local.name.researcherBerkovic, Samuel F
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
crisitem.author.deptEpilepsy Research Centre-
crisitem.author.deptEpilepsy Research Centre-
crisitem.author.deptNeurology-
crisitem.author.deptEpilepsy Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

76
checked on Jan 21, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.